Results 101 to 110 of about 4,961 (248)

Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window

Turkish Journal of Emergency Medicine, 2020
Dabigatran is a direct oral anticoagulant that is widely used for stroke prevention in patients with atrial fibrillation. We report a case of an 80-year-old stroke patient on dabigatran for permanent atrial fibrillation, who presented with an initial ...
Gorana Vukorepa, Sabina Deveđija*, Miljenko Crnjaković, Mirna Karakaš, Zeljka Cuk   +4 more
doaj   +1 more source

Anticoagulation and Antiplatelet Regimen in Cardiac Transplant. Clinical Characteristics, Outcomes, and Blood Product Transfusion

Clinical Transplantation, Volume 38, Issue 7, July 2024.
ABSTRACT Background We aimed to evaluate the characteristics, clinical outcomes, and blood product transfusion (BPT) rates of patients undergoing cardiac transplant (CT) while receiving uninterrupted anticoagulation and antiplatelet therapy. Methods A retrospective, single‐center, and observational study of adult patients who underwent CT was performed.
Maria del Val Groba Marco, Pedro Saavedra Santana, Luz Maria Gonzalez del Castillo, Mario Galvan Ruiz, Miguel de Fernandez de Sanmamed, Stefano Urso, Elisabet Guerra Hernández, Laura Quintana Paris, Michelle Tout Castellano, Jose Luis Romero Lujan, Eduardo Jose Caballero Dorta, Luisa Maria Guerra Dominguez, Antonio Garcia Quintana   +12 more
wiley   +1 more source

Design of small-molecule active-site inhibitors of the S1A family proteases as procoagulant and anticoagulant drugs [PDF]

, 2017
Vitamin K antagonists (VKA) have long been the default drugs for anticoagulant management in venous thrombosis. While efficacious, they are difficult to use due to interpatient dose–response variability and the risks of bleeding.
Banner D. W., Bode W., Budovich A., Cool D. E., Fritz H., Giansily-Blaizot M., Himber J., Mather T., Peter M. Fischer, Sun W. Y.   +9 more
core   +2 more sources

Chinese guidelines for the diagnosis and management of atrial fibrillation

Pacing and Clinical Electrophysiology, Volume 47, Issue 6, Page 714-770, June 2024.
Abstract Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, significantly impacting patients' quality of life and increasing the risk of death, stroke, heart failure, and dementia. Over the past two decades, there have been significant breakthroughs in AF risk prediction and screening, stroke prevention, rhythm control, catheter ...
Changsheng Ma, Shulin Wu, Shaowen Liu, Yaling Han   +3 more
wiley   +1 more source

JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias

Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
Yu‐ki Iwasaki, Takashi Noda, Masaharu Akao, Tadashi Fujino, Teruyuki Hirano, Koichi Inoue, Kengo Kusano, Toshiyuki Nagai, Kazuhiro Satomi, Tetsuji Shinohara, Kyoko Soejima, Yohei Sotomi, Shinya Suzuki, Teiichi Yamane, Tsukasa Kamakura, Hiroyuki Kato, Arimi Katsume, Yusuke Kondo, Kenji Kuroki, Hisaki Makimoto, Hiroshige Murata, Takafumi Oka, Nobuaki Tanaka, Nobuhiko Ueda, Hiro Yamasaki, Seigo Yamashita, Ryobun Yasuoka, Kenji Yodogawa, Kazutaka Aonuma, Takanori Ikeda, Toru Minamino, Hideo Mitamura, Akihiko Nogami, Ken Okumura, Hiroshi Tada, Takashi Kurita, Wataru Shimizu, on behalf of the Japanese Circulation Society and Japanese Heart Rhythm Society Joint Working Group   +37 more
wiley   +1 more source

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 44, Issue 5, Page 394-408, May 2024.
Abstract Previous meta‐analyses assessed andexanet alfa (AA) or prothrombin complex concentrate (PCC) products for the treatment of Factor Xa inhibitor (FXaI)‐associated major bleeding. However, they did not include recent studies or assess the impact of the risk of bias.
C. Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V. Hernandez, William L. Baker, Paul P. Dobesh, Heleen van Haalen, Kirsty Rhodes, Craig I. Coleman   +8 more
wiley   +1 more source

Anticoagulantes orais diretos, antídotos e possíveis interações [PDF]

, 2016
Monografia realizada no âmbito da unidade de Estágio Curricular do Mestrado Integrado em Ciências Farmacêuticas, apresentada à Faculdade de Farmácia da Universidade de CoimbraA terapêutica anticoagulante foi, durante um longo período e até há pouco tempo,
Graça, João Pedro Antunes
core  

Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: An update 2018 [PDF]

, 2018
Non-variceal upper gastrointestinal bleeding remains an important emergency condition, leading to significant morbidity and mortality. As endoscopic therapy is the 'gold standard' of management, treatment of these patients can be considered in three ...
Bjorkman, D.J. (David J.), Chan, F.K.L. (Francis K.L.), Chiu, P.C.Y. (Philip C.Y.), Goh, K.-L. (Khean-Lee), Gotoda, T. (Takuji), Ho, L.H.Y. (Lawrence H.Y.), Jensen, D.M. (Dennis), Jung, H.-Y. (Hwoon-Young), Kuipers, E.J. (Ernst J.), Lanas, A. (Angel), Lau, J.Y.W. (James), Reddy, N. (N.), Singh, R. (Rajvinder), Sollano, J. (José), Sugano, K. (Kentaro), Sung, J.J.Y. (Joseph), Wu, C.-Y. (Chun-Yin), Wu, K.-C. (Kai-Chun)   +17 more
core   +5 more sources

Hemiplegia in acute ischemic stroke: A comprehensive review of case studies and the role of intravenous thrombolysis and mechanical thrombectomy

Ibrain, Volume 10, Issue 1, Page 59-68, Spring 2024.
The accompanying paper presents a comprehensive review of case studies focusing on the impact of intravenous thrombolysis and mechanical thrombectomy within a 4.5‐h time frame on hemiplegia in patients with acute ischemic strokes. The study evaluates the effectiveness of these interventions in improving neurological symptoms and functional outcomes. It
Karen Adriana Carrillo Navarrete, Christian Chapa González   +1 more
wiley   +1 more source

State of play and future direction with NOACs: An expert consensus. [PDF]

, 2018
Atrial fibrillation (AF) and venous thromboembolism (VTE) are cardiovascular conditions significant in contemporary practice. In both, the use of anticoagulation with vitamin K antagonists (VKAs) has been traditionally used to prevent adverse events ...
A.J. Camm, A.T. Cohen, Ageno, Agnelli, Alings, Ansell, Ansell, Apostolakis, Avgil-Tsadok, Beyer-Westendorf, Beyer-Westendorf, Beyer-Westendorf, Bohula, Bouillon, Brunner-Ziegler, Caldeira, Caldeira, Camm, Cannon, Cohen, Cohen, Coleman, Connolly, Connolly, Connolly, Cronin-Fenton, De Caterina, De Caterina, De Caterina, De Caterina, Diener, Diener, Diener, Douketis, Easton, Eikelboom, Ensor, F. Verheugt, Fang, Fauchier, Forslund, Fox, Friberg, Friberg, Furugohri, G. Agnelli, G.Y. Lip, Gage, Gibson, Giugliano, Glund, Granger, Gross, Guo, H. Heidbuchel, Hankey, Heidbuchel, Heidbuchel, Heit, Heit, Hijazi, Hohnloser, Husted, Investigators, J.L. Zamorano, Kearon, Keeling, Khorana, Kirchhof, Kooiman, Kooistra, Larsen, Levy, Lip, Lip, Lip, Lip, Lip, Lublóy, Martinez, Masjuan, Mendell, Mendell, Miyasaka, Moore, Morgan, Mungall, Murphy, Márquez-Contreras, Nielsen, Oldgren, Paciaroni, Paciaroni, Patel, Perzborn, Peterson, Pinto, Pollack, Pollack, Price, Prins, Proietti, Proietti, R. De Caterina, Raskob, Renda, Roffi, Roldán, Ruff, Ruff, Sandén, Sardar, Sardar, Sarich, Schulman, Schulman, Senoo, Senoo, Shekelle, Sjögren, Song, Stacy, Stampfuss, Stangier, Steinberg, Tafur, The EINSTEIN investigators, The EINSTEIN–PE Investigators, van der Hulle, van Walraven, Verhamme, Vrijens, Watanabe, Weitz, Wolf, Zamorano   +135 more
core   +4 more sources